Cardiac troponin I (cTnI) is a cardiac biomarker reflecting myocardial injury and has been proven to detect myocardial damage from cancer chemotherapy or certain heart diseases, including HWD [12, 13]. This evidence concerns the gene TNNI3 and heart disorder.